Perforomist is a prescription drug that can treat COPD by opening up the airways to the lungs. This eMedTV page provides an overview of Perforomist, including information on how it works, how to use the nebulizer solution, and possible side effects.
Nausea, diarrhea, and dizziness are some of the most commonly reported side effects of Perforomist. This eMedTV Web page highlights other common Perforomist side effects and describes which side effects you should report to your doctor right away.
Perforomist, a prescription drug, can help treat the symptoms of COPD in adults. This eMedTV page discusses Perforomist uses in more detail, including information on symptoms of COPD and possible off-label Perforomist uses (such as treating asthma).
The standard Perforomist dose to treat COPD is one vial (20 mcg of Perforomist in 2 mL) inhaled twice daily. This eMedTV article further discusses Perforomist dosing guidelines and provides some tips for when and how to take your Perforomist dosage.
Drug interactions may occur if Perforomist is combined with certain medications. This selection from the eMedTV Web site takes an in-depth look at the medicines that can cause Perforomist drug interactions and describes the problems that can occur.
Perforomist can make certain conditions worse, such as hyperthyroidism, diabetes, and epilepsy. This part of the eMedTV archives provides other important Perforomist warnings and precautions, including information on who should not use the medication.
As this eMedTV article explains, some symptoms of a Perforomist (formoterol solution) overdose can include seizures and chest pain. This segment also covers some of the treatment options that are available for a Perforomist overdose.
It may not be safe to take Perforomist (formoterol solution) during pregnancy. This eMedTV page discusses the results of animal studies on Perforomist and pregnancy, and explains why the FDA has classified the drug as a pregnancy Category C medicine.
As this eMedTV page explains, it is not known if Perforomist (formoterol solution) passes through breast milk, because no human studies have been done on Perforomist and breastfeeding. This page also discusses the manufacturer's recommendations.
June 2021 is the earliest date that generic Perforomist (formoterol solution) could become available. This eMedTV page explains why generic Perforomist is currently unavailable and explains why formoterol solution is not a generic form of Perforomist.
